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Letter to the editor
End-of-life decisions in the United Kingdom
Clive Seale’s recently published article on end-of-life deci-
sions in the United Kingdom in 2007–2008 is presented as
an update of earlier findings from a survey performed in
2004.1 This 2004 survey used a questionnaire that was
developed to study end-of-life decision-making practices
in the Netherlands. Since 1990, it has been used in a series
of follow-up studies in the Netherlands and other
countries.2–7 In his new study, Seale has reworded the
key questions, ‘to adjust for the potential of the original
Dutch wording to overestimate the prevalence of certain
end-of-life decisions’. This adaptation coincides with sub-
stantial lower rates of end-of-life decisions where hasten-
ing the end of life had not been the explicit intention of the
physician as compared with 2004. Several aspects of
Seale’s article deserve further attention.
Seale’s adaptation consists of separating three of the
original seven key questions into different sub questions
to distinguish acts and expectations about the conse-
quences of these acts regarding hastening of the end of
life. In the original questionnaire, acts and expectations
were combined because using or forgoing treatment only
involves an end-of-life decision when hastening of the end
of life is an expected (or intended) effect. The four remain-
ing questions about the physicians’ intention with respect
to hastening the end of life while performing these acts
remained largely unchanged. Although the original ques-
tionnaire was designed to fully assess the potential impact
of current medical decision making on the hastening of
death, Seale’s rewording seems to aim at assessing the fre-
quency of those acts where physicians are willing to admit
the potential life-shortening effect of their act in a separate
question. The original wording was aimed at being broad;
but the adapted wording seems to be aimed at being nar-
row. It should be noted that the original questions have
extensively been validated not only in the 1990 and 1995
studies in the Netherlands but also in the 2001 study in six
European countries. Validity was further enhanced by a
guarantee of absolute anonymity for all respondents.
Unfortunately, no mention is made in Seale’s article of
any effort to assess the validity of the new wording. Seale’s
conclusion that the new results more closely reflect the
realities of UK end-of-life care because some of the mis-
leading assumptions contained in the original question-
naire were removed is thus unsubstantiated.
The comparability of Seale’s study with other studies is
limited also because of the adaptation in the wording of
key questions. All studies following the Dutch design used
samples of death cases to estimate the occurrence of end-
of-life decisions before death. The UK studies, in contrast,
used samples of physicians, which introduces various
sources of potential bias: first, physicians are asked to
identify cases themselves, which may result in an overrep-
resentation of memorable or correct cases, and second,
responding physicians may not be representative for all
physicians, which is shown in Seale’s study where physi-
cians who did not reply partly felt that they did not have
to because they did not normally attend dying patients.
Moderate response rates in Seale’s studies enhance this
problem. Response rates in the studies following the
Dutch design were substantially higher, which may partly
be attributed to the endorsement of the studies by author-
itative medical organisations.
The Dutch approach to studying end-of-life decision
making is aimed at supporting caregivers in their efforts
to provide careful, transparent end-of-life care, which
enhances the quality of the last stage in life while fully
taking into account medical, ethical and legal considera-
tions. Even the 2007–2008 estimates in Clive Seale’s study
suggest that the impact of medical decision-making on
dying is substantial in the United Kingdom, as it is else-
where. Acknowledgement of this reality is very
worthwhile.
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